Columbus, OH 的 前列腺癌 臨床試驗
24 項針對 前列腺癌 的研究正在 Columbus（約 30 英里範圍內）及其周邊地點尋找參與者。開啟研究以查看參與資格及聯絡研究團隊的方式。
官方研究文本（英文）
正在為研究招募對象嗎？將此頁面置頂展示 — $99 / 30 天 →
Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial
招募中3 期
- Ohio State University Comprehensive Cancer Center, Columbus
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
招募中觀察性研究歡迎健康志工
- Ohio State University Comprehensive Cancer Center, Columbus
- Mount Carmel East Hospital, Columbus
- The Mark H Zangmeister Center, Columbus
- 還有 8 項
Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial
招募中2 期
- Ohio State University Comprehensive Cancer Center, Columbus
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
招募中2 期
- Ohio State University Comprehensive Cancer Center, Columbus
- Mount Carmel East Hospital, Columbus
- Columbus Oncology and Hematology Associates Inc, Columbus
- 還有 11 項
Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy
招募中2/3 期
- Central Ohio Urology Group, Gahanna · 距離 7 英里
A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer
招募中3 期
- The Ohio State University, Columbus
Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC
招募中3 期
- Central Ohio Urology Group, Gahanna · 距離 7 英里
A Study of Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men With High-risk Prostate Cancer With a BRCA Mutation
招募中3 期
- Research Site, Columbus
A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
招募中3 期
- The James Cancer Hospital and Solove Research Institute at The Ohio State University Comprehensive C ( Site 0061), Columbus
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
招募中3 期
- Ohio State University Comprehensive Cancer Center, Columbus
- Riverside Methodist Hospital, Columbus
- Grant Medical Center, Columbus
- 還有 4 項
A Phase 1b/2a Study of Pocenbrodib as Monotherapy and in Combination With Darolutamide in Participants With mCRPC
招募中1/2 期
- The Ohio State University, Columbus
Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
招募中3 期
- Ohio State University Comprehensive Cancer Center, Columbus
Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)
招募中1 期
- The Ohio State University, Columbus
Evaluation of Neoadjuvant Xaluritamig in Localized Prostate Cancer
招募中1 期
- The Ohio State University, Columbus
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
招募中3 期
- Ohio State University Comprehensive Cancer Center, Columbus
Testing the Safety and Effectiveness of Radiation-based Treatment (Lutetium Lu 177 Dotatate) for Metastatic Prostate Cancer That Has Neuroendocrine Cells
招募中2 期
- Ohio State University Comprehensive Cancer Center, Columbus
A Clinical Study of KTX-2001 in Subjects With Metastatic Castration-Resistant Prostate Cancer (STRIKE-001)
招募中1 期
- The Ohio State University Comprehensive Cancer Center, Columbus
Study of CX-5461 in Patients With Solid Tumours and BRCA1/2, PALB2 or Homologous Recombination Deficiency (HRD) Mutation
招募中1 期
- Ohio State University-James Cancer Hospital and Solove Research Institute, Columbus
A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies
招募中1/2 期
- Stefanie Spielman Comprehensive Breast Center, Columbus
Effects of Relugolix vs Leuprolide on Cardiac Function in Patients With Prostate Cancer
招募中2 期
- Ohio State University Comprehensive Cancer Center, Columbus
A Study of MT-4561 in Patients With Various Advanced Solid Tumors
招募中1/2 期
- The James Cancer Hospital and Solove Research Institute at The Ohio State University Comprehensive Cancer Center, Columbus
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
招募中觀察性研究
- Massive Bio SYNERGY-AI site, Columbus
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
招募中3 期
- Ohio State University Comprehensive Cancer Center, Columbus
FK-PC101 as Adjuvant Therapy for Men With High-Risk Prostate Cancer
招募中2 期
- Central Ohio Urology Group, Gahanna · 距離 7 英里
其他城市的 前列腺癌 試驗
- New York City, NY103 項研究
- Houston, TX76 項研究
- Los Angeles, CA61 項研究
- Boston, MA59 項研究
- St. Louis, MO46 項研究
- Chicago, IL45 項研究
- San Francisco, CA45 項研究
- Philadelphia, PA44 項研究
- Baltimore, MD43 項研究
- Nashville, TN42 項研究
- Seattle, WA42 項研究
- Washington, DC38 項研究
Columbus 的其他研究
- 非小細胞肺癌56 項研究
- 乳癌39 項研究
- 卵巢癌39 項研究
- 癌症（所有類型）38 項研究
- 肺癌37 項研究
- 急性髓系白血病35 項研究
- 慢性淋巴性白血病28 項研究
- 轉移性癌症27 項研究
- 子宮內膜癌25 項研究
- 大腸直腸癌24 項研究
- 多發性骨髓瘤24 項研究
- 黑色素瘤21 項研究
資料來源：ClinicalTrials.gov，擷取日期 2026年10月5日。各研究自行設定資格標準；由研究團隊決定參與者資格。